Literature DB >> 28515225

Energy metabolic pathways control the fate and function of myeloid immune cells.

Amir A Al-Khami1,2, Paulo C Rodriguez3, Augusto C Ochoa4,5.   

Abstract

The past decade has seen a significant interest in investigating the intracellular metabolism of cells of the immune system. This has increased the realization that immune cells endure metabolic reprogramming upon responding to pathogen-derived or inflammatory signals. More importantly, not only does this metabolic switch provide for the bioenergetic and biosynthetic demands but also it, in a highly specific manner, determines the cellular fate and function. In this review, we discuss the metabolic aspects that regulate the differentiation and function of myeloid cells, pivotal for both innate and adaptive immunity. The manipulation of these pathways can alter the function of these cells and therefore, could provide novel therapeutic approaches in cancer and other chronic inflammatory conditions. © Society for Leukocyte Biology.

Entities:  

Keywords:  MDSC; dendritic cell; macrophage; neutrophil

Mesh:

Year:  2017        PMID: 28515225      PMCID: PMC5505747          DOI: 10.1189/jlb.1VMR1216-535R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  157 in total

1.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

Review 2.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

3.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

4.  Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases.

Authors:  M W Cleeter; J M Cooper; V M Darley-Usmar; S Moncada; A H Schapira
Journal:  FEBS Lett       Date:  1994-05-23       Impact factor: 4.124

5.  Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation.

Authors:  Juan-Carlos Rodríguez-Prados; Paqui G Través; Jimena Cuenca; Daniel Rico; Julián Aragonés; Paloma Martín-Sanz; Marta Cascante; Lisardo Boscá
Journal:  J Immunol       Date:  2010-05-24       Impact factor: 5.422

6.  GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Babak Baban; Heather P Harding; Yuhong Zhang; David Ron; Andrew L Mellor
Journal:  Immunity       Date:  2005-05       Impact factor: 31.745

7.  CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis.

Authors:  Bing Zhu; Yoshio Bando; Sheng Xiao; Kaiyong Yang; Ana C Anderson; Vijay K Kuchroo; Samia J Khoury
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

8.  Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages.

Authors:  P Newsholme; R Curi; S Gordon; E A Newsholme
Journal:  Biochem J       Date:  1986-10-01       Impact factor: 3.857

9.  Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer.

Authors:  Srinivas Nagaraj; Kapil Gupta; Vladimir Pisarev; Leo Kinarsky; Simon Sherman; Loveleen Kang; Donna L Herber; Jonathan Schneck; Dmitry I Gabrilovich
Journal:  Nat Med       Date:  2007-07-01       Impact factor: 53.440

10.  Mitochondrial membrane potential in human neutrophils is maintained by complex III activity in the absence of supercomplex organisation.

Authors:  Bram J van Raam; Wim Sluiter; Elly de Wit; Dirk Roos; Arthur J Verhoeven; Taco W Kuijpers
Journal:  PLoS One       Date:  2008-04-23       Impact factor: 3.240

View more
  18 in total

Review 1.  Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.

Authors:  Jackie E Bader; Kelsey Voss; Jeffrey C Rathmell
Journal:  Mol Cell       Date:  2020-06-18       Impact factor: 17.970

Review 2.  Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting.

Authors:  Vijay Kumar
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

Review 3.  The cellular metabolic landscape in the tumor milieu regulates the activity of myeloid infiltrates.

Authors:  Eslam Mohamed; Amir A Al-Khami; Paulo C Rodriguez
Journal:  Cell Mol Immunol       Date:  2018-03-22       Impact factor: 11.530

4.  Polymorphonuclear myeloid-derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer.

Authors:  Alessio Ugolini; Vladimir A Tyurin; Yulia Y Tyurina; Evgenii N Tcyganov; Laxminarasimha Donthireddy; Valerian E Kagan; Dmitry I Gabrilovich; Filippo Veglia
Journal:  JCI Insight       Date:  2020-08-06

5.  Shiny GATOM: omics-based identification of regulated metabolic modules in atom transition networks.

Authors:  Mariia Emelianova; Anastasiia Gainullina; Nikolay Poperechnyi; Alexander Loboda; Maxim Artyomov; Alexey Sergushichev
Journal:  Nucleic Acids Res       Date:  2022-05-27       Impact factor: 19.160

6.  Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells.

Authors:  Amir A Al-Khami; Liqin Zheng; Luis Del Valle; Fokhrul Hossain; Dorota Wyczechowska; Jovanny Zabaleta; Maria D Sanchez; Matthew J Dean; Paulo C Rodriguez; Augusto C Ochoa
Journal:  Oncoimmunology       Date:  2017-06-30       Impact factor: 8.110

Review 7.  Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression.

Authors:  Robin Maximilian Awad; Yannick De Vlaeminck; Johannes Maebe; Cleo Goyvaerts; Karine Breckpot
Journal:  Front Immunol       Date:  2018-08-31       Impact factor: 7.561

Review 8.  STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity.

Authors:  Yu-Lin Su; Shuvomoy Banerjee; Seok Voon White; Marcin Kortylewski
Journal:  Int J Mol Sci       Date:  2018-06-19       Impact factor: 5.923

Review 9.  Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression.

Authors:  Viktor Fleming; Xiaoying Hu; Rebekka Weber; Vasyl Nagibin; Christopher Groth; Peter Altevogt; Jochen Utikal; Viktor Umansky
Journal:  Front Immunol       Date:  2018-03-02       Impact factor: 7.561

Review 10.  Immunometabolism: new insights and lessons from antigen-directed cellular immune responses.

Authors:  Renata Ramalho; Martin Rao; Chao Zhang; Chiara Agrati; Giuseppe Ippolito; Fu-Sheng Wang; Alimuddin Zumla; Markus Maeurer
Journal:  Semin Immunopathol       Date:  2020-06-09       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.